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Introduction 
Primary cardiac tumors are a rare entity; one-
fourth of them are malignant [1]. Cardiac 
sarcomas are the most common histopathological 
subtype, commonly arising from the right atrium 
(RA) [2]. Angiosarcomas are uncommon 
aggressive malignant neoplasms with a high rate 
of local recurrence and systemic metastases. This 
degree of malignancy renders the prognosis very 
poor, with high mortality within a few months of 
diagnosis [2]. The standard treatment is not well-
established; however, surgical management is 
the preferred modality in fit patients [3]. Patients 
with primary cardiac angiosarcoma are usually 
asymptomatic; symptoms appear when the tumor 
reaches a certain size or when local or distant 
metastases occur [2]. Outcomes of minimally 
invasive resection of cardiac angiosarcoma are 
rarely reported in the literature. We present a case 
of right atrial angiosarcoma in a young male who 
had a minimally invasive tumor resection 
approach.   
Case Presentation: 
A 28-years-old gentleman was presented with 
a two-month history of dyspnea on exertion (New 
York Heart Association (NYHA) class III), followed 
by chest pain upon lying flat and palpitations. The 
patient had no comorbidity and was healthy prior 
to this presentation. Echocardiography showed a 
pericardial effusion and RA mass. The patient had 
pericardiocentesis to relieve the dyspnea before 
further investigations. (Figure 1) 
The chest computed tomography scan (CT) 
showed a large soft tissue mass from the RA with 
an adjacent pericardial thickening.  The mass was 
compressing the superior vena cava.  There was no 
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Figure 1: ECHO view showing large homogeneous 
fixed echogenic mass with regular borders seen in the 
right atrium measuring 4.5 x 2.5 cm. 
mediastinal, axillary, or supraclavicular 
lymphadenopathy.  Both lungs appeared normal 
with no intrapulmonary mass or nodule, and there 
was no destructive bony lesion.  
The patient was scheduled to excise the mass 
through a minimally invasive right mini-
thoracotomy with femoral cannulation. 
Intraoperative inspection revealed a large mass 
with a pericardial invasion involving the entire RA 
free wall and associated with extensive pericardial 
adhesion. The RA wall was resected entirely and 
sent for pathology. (Figure 2)  
Figure 2: Surgical specimen with the right atrial free 
wall with invasive mass and signs of necrosis 
The atrial wall was constructed using an 
autologous pericardial patch. Histopathology 
revealed an intracardiac mass that invaded the 
entire thickness of the atrial wall. There was no 
lymphovascular invasion; however, the tumor 
extended to the resection margin. This 
pathological finding was consistent with 
angiosarcoma (Figure 3). Staging workup showed 
no evidence of metastatic disease. The patient 
overall Eastern Cooperative Oncology Group 
(ECOG) performance scale was one. 
The patient refused postoperative 
chemotherapy and discharged home after an 
uneventful postoperative course. A positron 
emission tomography (PET) scan was done two 
months after surgery and showed bone 
metastasis. Chemotherapy with adjuvant 
paclitaxel 80mg/m2 weekly and denosumab 
120mg/monthly was started. After 12 cycles, PET 
CT showed partial response.  A repeat metastatic 
workup six months later showed vertebral spine 
and liver metastasis. Palliative radiotherapy was 
applied, and the patient was started on the second 
line of chemotherapy with ifosfamide and 
doxorubicin. 
Discussion 
Primary cardiac angiosarcoma has a poor 
prognosis, with a mean survival of 3.8 months 
without surgical resection [2]. Survival is affected 
by tumor size and tumor stage at the time of 
diagnosis and the presence of local or distant 
metastases. [2]. Surgical resection is widely 
recommended for localized tumors; it can 
improve survival [3]. Heart transplant has been 
utilized as a surgical option for primary localized 
cardiac sarcoma; however, it did not change long-
term outcomes [4]. Although chemotherapy and 
radiation therapy benefits are still under 
investigation, an aggressive approach using a 
multimodality regimen with various combinations 
of surgery, chemotherapy, and radiation therapy 
has been proposed with some potential 
improvement of survival [2]. Some authors 
suggested neoadjuvant chemotherapy to 
decrease the tumor size aiming at total surgical 
resection. They have reported a median survival 
time of 27 months, and one patient lived for 9.5 
years after surgery [4].





Figure 3: Hematoxylin and eosin (H&E) histopathology and immunohistochemistry examination. (A): low power 
examination of large undifferentiated malignant neoplasm invading the adjacent cardiac wall (H&E: 4x). (B): Cardiac 
neoplasm composed of highly pleomorphic epithelioid cells, with a high nuclear to cytoplasmic ratio and prominent 
mitosis. Extravasated red blood cells are seen between tumor cells (H&E: 10x). (C): Neoplastic cells are diffusely and 
strongly positive for CD31 (10x). (D): Neoplastic cells are diffusely and strongly positive for CD34 (10x).    
Minimally invasive resections of cardiac 
angiosarcoma are rarely reported in the literature. 
In this case, we performed a minimally invasive 
left thoracotomy, and intraoperative inspection 
revealed a large tumor invading the pericardium. 
We think that this approach is feasible and does 
not increase surgical risk. Tumor invasion of the 
pericardium warranted postoperative 
chemotherapy. However, the patient refused 
further treatment and presented after a few 
months with metastatic disease. We believe that 
early diagnosis and intervention can change the 
fate of the disease. The feasibility of minimally 
invasive resection was demonstrated in another 
series of 225 patients; most of them were cardiac 
myxoma. They performed mini-thoracotomy in 12 
patients and robotic resection in 60 patients. One 
patient had cardiac sarcoma and had a 
conventional approach [5]. 
Conclusion 
In conclusion, right atrial angiosarcoma could 
present with vague signs and symptoms, and 
minimally invasive resection is feasible. 
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